Announcements

Archive by year: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |

Date	Title	Format
06/12/2005	December City Presentation
10/10/2005	EGM Statement
28/09/2005	Research Update
22/09/2005	Declaration of Shareholding in ReGen Therapeutics Plc
20/09/2005	Declaration of Shareholding in ReGen Therapeutics Plc
15/09/2005	Committed Share Finance Facility
15/09/2005	ReGen Therapeutics Plc places £1,556,000 of shares
15/09/2005	Interim Results for the Six Months’ to 30 June 2005
06/09/2005	ReGen Acquires Rights To New Use for Well Known Drug
10/08/2005	ReGen Therapeutics announces grant of U.S. patent on use of Colostrinin(tm) to promote induction of Cytokines
18/07/2005	ReGen Therapeutics Plc Appoints New Broker
27/06/2005	Research Update
20/06/2005	ReGen Achieves Production Scale-Up Milestone for Colostrinin(TM)
13/06/2005	Director Shareholding
24/04/2005	Results of Annual General Meeting and Directorate Change
15/03/2005	Statement re ADR's
08/03/2005	Regen Therapeutics Plc appoints additional non-executive director
04/03/2005	ReGen Therapeutics announces grant of U.S. patent on use of Colostrinin in Dementia
14/02/2005	Regen Therapeutics announces grant of U.S. patent on use of Colostrinin(tm) to promote neuronal cell differentiation
14/02/2005	Disclosure of notifiable interest - Disposal of shares
09/02/2005	Preliminary Results 2004
07/02/2005	Disclosure of notifiable interest - Disposal of shares
01/02/2005	Substantial shareholding

If you are unable to view the PDF documents you may need to download the free Adobe Reader